Development of Polymer and Surfactant Based Naringenin Nanosuspension for Improvement of Stability, Antioxidant, and Antitumour Activity

Figure 8

MCF-7 cells were incubated with naringenin solution, HPMC-, and SDS-stabilized naringenin nanosuspension formulations at 100 µg/ml to induce morphological changes: (a) 24 hours (NAR); (b) 48 hours (NAR); (c) 24 hours (NAR-NS-HPMC); (d) 24 hours (NAR-NS-SDS); (e) 48 hours (NAR-NS-SDS); (f) 48 hours (NAR-NS-HPMC).

(a)

(b)

(c)

(d)

(e)

(f)